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Abstract
Background: Pancreatic metastases from previously treated renal cell carcinoma are uncommon.
Surgical resection of pancreatic metastasis remains the only worthwhile modality of treatment.
Case presentation: A case where pancreatic metastasis from previously resected right sided
renal cell carcinoma was resected with a subtotal left pancreatectomy is described. An unusual
feature was the presence of a large splenic vein tumor thrombus extending into the portal vein with
associated portal hypertension. The patient underwent an uneventful portal vein resection with
primary anastomosis.
Conclusion: This is possibly the first documented case of portal vein renal tumor thrombosis in
a case of isolated pancreatic metastasis from previously operated renal cell carcinoma in published
world surgical literature.
Background
Pancreatic metastases from previously treated renal cell
carcinoma are known but uncommon. Surgical resection
of pancreatic metastasis remains the only worthwhile
modality of treatment. We describe our experience where
a pancreatic metastasis from previously resected right
sided renal cell carcinoma was resected with a subtotal left
pancreatectomy with portal vein resection and primary
anastomosis for a renal tumor thrombus in the splenic
and portal vein.
Case presentation
A 62 year old patient was treated for right sided renal cell
carcinoma by a radical nephrectomy in March 2004. In
February 2005, he complained of abdominal pain and
weight loss and on radiologic evaluation by a computed
tomography (CT) scan, was diagnosed to have a pancre-
atic mass with evidence of portal hypertension and a por-
tal vein thrombosis (Figure 1). In view of the solitary
lesion with a differential diagnosis of primary pancreatic
pathology or metastasis from renal cell carcinoma, the
patient was subjected to an exploratory laparotomy in
March 2005. Exploratory findings were those of a large
pancreatic body and tail mass associated with signs of por-
tal hypertension. After a careful assessment of resectability
that included mobilization of the pancreatic neck from
the superior mesenteric vein, a decision to perform a left
sided pancreatectomy with splenectomy was taken. Divi-
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sion of the pancreatic neck by a vascular stapler confirmed
our preoperative radiological findings. There was a large
tumor thrombus in the splenic vein and it was extending
via its confluence with the superior mesenteric vein into
the portal vein occupying approximately 80% of its entire
lumen. In view of these findings, a portal vein segment
resection of 2.5 cm with primary anastomosis was added
to the stapled left pancreatectomy and splenectomy. The
patient had a smooth postoperative recovery and was dis-
charged from the hospital on the 9th postoperative day.
Final histopathology confirmed a metastatic renal cell car-
cinoma to the pancreas with tumor thrombus in the por-
tal vein (Figure 2). Furthermore, the thrombus was
adherent to the wall of the vein (Figure 2, inset). The
patient refused any form of adjuvant treatment and died 5
months later with systemic metastases.
Discussion
Our case raised three questions. First, is a radial resection
justified in view of a locally advanced (metastatic) pathol-
ogy? Second, is a major pancreatic resection safe enough
in these patients and last but not the least, the rarity of our
intraoperative findings that prompted us to write this
report.
Despite the unsatisfactory survival in our case, isolated
pancreatic metastasis from renal call carcinoma are best
treated by surgical resection. While the 5 – year survival
for metastatic renal cell carcinoma is poor and hovers
around 9% [1], aggressive resection of pancreatic metasta-
sis from renal and various other tumors has shown a bet-
ter survival [2-5]. Moussa et al., reported a mean survival
of 61 months after resection for metastasis to the pancreas
from renal cell carcinoma [3]. This could also be partly
explained by the fact that an R0 resection of renal cell car-
cinoma metastasis to the pancreas is more likely than an
R0 resection in primary pancreatic neoplasms and the
resectability rate is around 80% [6]. Furthermore, if the
disease free interval between the primary surgery and the
resection of pancreatic metastasis is long, a better out-
come can often be expected. In our specific case, this inter-
val was only 11 months.
Pancreatectomy with portal vein resection is well
described. A number of large studies have evaluated the
safety of pancreatectomy with resection of tumor infil-
trated retropancreatic vessels [7,8]. The conclusions from
these studies were that segmental venous resection can be
performed safely and that localized invasion of the vessel
wall is not associated with a poor prognosis. Furthermore,
since the results of alternative oncologic modalities con-
tinue to remain worse, it appears that aggressive pancre-
atic resection remains the best treatment option.
Portal hypertension in primary renal cell carcinoma is
extremely rare and a medline search of recent literature
revealed a solitary report of a hypernephroma infiltrating
the pancreas, causing splenic vein thrombosis with result-
ant gastric varices as a manifestation of portal hyperten-
sion [9]. However, a medline search performed with the
key words "renal cell carcinoma, pancreatic metastasis, portal
vein thrombosis" did not reveal a single documented case of
splenic and portal vein thrombosis in pancreatic metasta-
sis from a previously treated renal cell carcinoma.
A renal cell carcinoma thrombus projects into the lumen of  the portal vein and is partially attached to the venous wall  (inset) Figure 2
A renal cell carcinoma thrombus projects into the lumen of 
the portal vein and is partially attached to the venous wall 
(inset). (H & E staining. Original figure magnification: 50 ×; 
inset magnification 100 ×.)
CT scan showing a pancreatic body mass and tail mass (white  arrows) with portal vein thrombus (black arrows) Figure 1
CT scan showing a pancreatic body mass and tail mass (white 
arrows) with portal vein thrombus (black arrows).Publish with BioMed Central    and   every 
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Summary
While our group has recently published a single center
experience with metastases to the pancreas from renal
tumors [10], this rare clinical situation is a new recent
addition and adds to the pool of existing information
regarding metastatic lesions of renal cell carcinoma to the
pancreas. Thus our case, probably for the first time in pub-
lished literature, documents the presence of splenic and
portal vein tumor thrombus in a case of pancreatic metas-
tasis from renal cell carcinoma. Radical surgery remains
the treatment mainstay and portal vein resection, espe-
cially in high volume centers, does not influence the peri-
operative outcome in such locally advanced surgical
scenarios. While our series has documented a degree of
survival benefit for metastases to the pancreas from renal
cell carcinomas [10], the long-term outcome of such radi-
cal procedures needs a larger collective experience to reach
a meaningful conclusion.
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